Search hospitals > Virginia > Charlottesville

University of Virginia Health System

Claim this profile
Charlottesville, Virginia 22901
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Coronary Artery Disease
Conducts research for Ovarian Cancer
Conducts research for Heart Failure
398 reported clinical trials
52 medical researchers
Photo of University of Virginia Health System in CharlottesvillePhoto of University of Virginia Health System in CharlottesvillePhoto of University of Virginia Health System in Charlottesville

Summary

University of Virginia Health System is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Lung Cancer, Cancer, Coronary Artery Disease, Ovarian Cancer, Heart Failure and other specialties. University of Virginia Health System is involved with conducting 398 clinical trials across 567 conditions. There are 52 research doctors associated with this hospital, such as Linda Duska, MD, Scott Lim, MD, Richard D. Hall, and Matthew J. Reilley.

Area of expertise

1Lung Cancer
Global Leader
University of Virginia Health System has run 26 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive
2Cancer
Global Leader
University of Virginia Health System has run 24 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
ARID1A positive

Top PIs

Clinical Trials running at University of Virginia Health System

Stroke
Cancer
Lung Cancer
Heart Failure
Prostate Cancer
Ovarian Cancer
Atrial Fibrillation
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Lymphoma
Image of trial facility.

Anti-Coagulant + Anti-Platelet Therapy

for Stroke Prevention

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Anticoagulation + Antiplatelet Therapy

for Post-Operative Atrial Fibrillation

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Recruiting2 awards Phase 32 criteria
Image of trial facility.

Endovascular Thrombectomy

for Stroke

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
Recruiting1 award N/A2 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Virginia Health System?
Where is University of Virginia Health System located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Virginia Health System accept?
What awards or recognition has University of Virginia Health System received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security